Showing results (1271-1280 of 1,598) with videos related to
Sort By:
Pageof 160
Computational and Structural Biotechnology Journal|April 24, 2023
A new approach: Evaluation of necroptosis and immune status enables prediction of the tumor microenvironment and treatment targets in pancreatic cancerSi-Yuan Lu, Jie Hua, Jiang Liu, et al.Human Gene Therapy|April 13, 2018
CRISPR/Cas9 Inhibits Multiple Steps of HIV-1 InfectionLijuan Yin, Siqi Hu, Shan Mei, et al.Plos One|August 11, 2017
Correction: Comprehensive target capture/next-generation sequencing as a second-tier diagnostic approach for congenital muscular dystrophy in TaiwanWen-Chen Liang, Xia Tian, Chung-Yee Yuo, et al.Cancer Research|October 26, 2018
PIN1 Maintains Redox Balance via the c-Myc/NRF2 Axis to Counteract Kras-Induced Mitochondrial Respiratory Injury in Pancreatic Cancer CellsChen Liang, Si Shi, Mingyang Liu, et al.Molecular Cancer Research : MCR|January 22, 2017
Oncogenic KRAS Targets MUC16/CA125 in Pancreatic Ductal AdenocarcinomaChen Liang, Yi Qin, Bo Zhang, et al.Development (Cambridge, England)|April 30, 2015
Lin28 promotes the proliferative capacity of neural progenitor cells in brain developmentMei Yang, Si-Lu Yang, Stephanie Herrlinger, et al.Oncotarget|May 15, 2015
MicroRNA-33a-mediated downregulation of Pim-3 kinase expression renders human pancreatic cancer cells sensitivity to gemcitabineChen Liang, Xian-Jun Yu, Xiao-Zhong Guo, et al.Theranostics|August 27, 2025
The Role of Senescence, its Therapeutic Relevance and Clinical Implications in the Tumor MicroenvironmentHanzhe Shi, Mingming Xiao, Yangyi Li, et al.Iscience|July 3, 2024
An HIV-1 CRISPR-Cas9 membrane trafficking screen reveals a role for PICALM intersecting endolysosomes and immunityPaola Guizar, Ana Luiza Abdalla, Anne Monette, et al.BMC Cancer|January 17, 2024
Efficacy and safety of anti-PD-1 inhibitor versus anti-PD-L1 inhibitor in first-line treatment of extensive-stage small cell lung cancer: a multicenter retrospective studyBoyu Qin, Lingli Xin, Chen Liang, et al.Pageof 160